Projects per year
Personal profile
Personal profile
Dr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of SWOG trials, and industry trials of novel targeted agents.
Research interests
Dr. Bernicker’s research focuses on looking at different therapeutic approaches, such as targeted therapies and immunotherapies, in the treatment of lung cancer. By understanding how to identify patients at risk for relapse after surgery or those who can be spared the toxicities of chemotherapy, the immune system can be stimulated to preferentially destroy tumor cells, spare normal tissues, and improve patient survival along with the development of less toxic therapeutics. Eventually, the goal is to be able to offer new therapies and clinical trials to patients at Methodist with any stage of non-small cell lung cancer or small cell lung cancer.
Education/Academic qualification
Medical Oncology, Clinical Fellowship, Baylor College of Medicine
Jul 1 1994 → Sep 30 1996
Award Date: Sep 30 1996
MD, Baylor College of Medicine
May 1 1990 → Jun 1 1994
Award Date: Jun 1 1994
Internal Medicine, Residency, Baylor College of Medicine
Jan 1 1991 → Jun 30 1993
Award Date: Jun 30 1993
Internship, Dallas County Hospital -Parkland Memorial Hospital
Jan 1 1990 → Jan 1 1991
Award Date: Jan 1 1991
Research Area Keywords
- Cancer
- Clinical Translation & Trials
- Clinical Care
Free-text keywords
- Cancer research
- Lung cancer
- Targeted therapeutics
Fingerprint Dive into the research topics where Eric H. Bernicker is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 16 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Phase III_OlanzapineFosaprepitant_Highly Emetogenic Chemotherapy Patients_ALLIANCE A221602
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K., Niravath, P. A. & Randhawa, J.
9/28/20 → …
Project: Clinical Trial
Phase III_MRx0518Pembrolizumab_Solid Tumors_4D Pharma MRx0518-I-002
Bernicker, E. H., Darcourt, J. & Zhang, J.
9/25/20 → …
Project: Clinical Trial
A Phase 2, Multicenter, Single-arm Study of Retreatment With Brentuximab Vedotin in Subjects With Relapsed or Refractory Classic Hodgkin Lymphoma (cHL) or CD30-expressing Peripheral T Cell Lymphoma (PTCL)
Pingali, S. R., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Petkova, J., Randhawa, J., Rice, L. & Singh, M.
7/8/20 → …
Project: Clinical Trial
A Phase 2, Multicenter, Open-label, Safety and Efficacy Study of XERMELO® (Telotristat Ethyl) Plus First-line Chemotherapy in Patients With Locally Advanced, Unresectable, Recurrent or Metastatic Biliary Tract Cancer (BTC)
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
4/27/20 → …
Project: Clinical Trial
Research Output
Cancer cachexia: A multifactoral disease that needs a multimodal approach
Stubbins, R., Bernicker, E. H. & Quigley, E. M., Mar 1 2020, In : Current opinion in gastroenterology. 36, 2, p. 141-146 6 p.Research output: Contribution to journal › Review article
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
COVID-19 and Cancer Consortium, Jun 20 2020, In : The Lancet. 395, 10241, p. 1907-1918 12 p.Research output: Contribution to journal › Article
72
Scopus
citations
Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
Anand, K., Phung, T. L., Bernicker, E. H., Cagle, P. T., Olsen, R. J. & Thomas, J. S., Sep 2020, In : Clinical Lung Cancer. 21, 5, p. 437-442 6 p.Research output: Contribution to journal › Article
Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database
Messer, J. A., Zuhour, R. J., Haque, W., Lewis, G. D., Schefler, A. C., Wong, A., Bernicker, E. H., Chevez-Barrios, P., Michelle Quan, E., Farach, A., Butler, E. B., Hatch, S. S. & Teh, B. S., 2020, In : Journal of Contemporary Brachytherapy. 12, 4, p. 303-310 8 p.Research output: Contribution to journal › Article
A matter of comprehensive informed consent: Short-term mortality rates with definitive treatment options in elderly stage i NSCLC
Dalwadi, S. M., Savjani, R. R., Bernicker, E. H., Butler, E. B., Teh, B. S. & Farach, A. M., Nov 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 11, p. 851-855 5 p.Research output: Contribution to journal › Article